Table 1.
Patient demographics
| Parameters | Patient numbers (n=28) |
|---|---|
| Sex (M/F) | 22/6 |
| Age (mean, range) | 55.6 years (35-72) |
| Tumor type (n %) | |
| Cholangiocarcinoma | 14 |
| Hepatocellular carcinoma | 5 |
| Gall bladder carcinoma | 9 |
| Underlying liver damage/Systemic disease | |
| Cirrhosis | 19 |
| Neoadjuvant chemotherapy | 5 |
| Diabetes mellitus | 6 |
| PVE approach | |
| Ipsilateral PVE | 6 |
| Contralateral PVE | 22 |